|
1
|
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
|
Lancet Oncol
|
2013
|
2.48
|
|
2
|
Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer.
|
Obstet Gynecol
|
2009
|
2.27
|
|
3
|
Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
|
Gynecol Oncol
|
2003
|
2.11
|
|
4
|
Folate receptor alpha as a tumor target in epithelial ovarian cancer.
|
Gynecol Oncol
|
2008
|
2.01
|
|
5
|
Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
|
Gynecol Oncol
|
2006
|
1.77
|
|
6
|
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
|
Nat Commun
|
2013
|
1.73
|
|
7
|
Folate receptor overexpression is associated with poor outcome in breast cancer.
|
Int J Cancer
|
2007
|
1.65
|
|
8
|
Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder.
|
Mod Pathol
|
2008
|
1.61
|
|
9
|
Endometrial stromal sarcoma: treatment and patterns of recurrence.
|
Int J Gynecol Cancer
|
2009
|
1.61
|
|
10
|
Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study.
|
Cancer
|
2008
|
1.56
|
|
11
|
Frozen section evaluation of cervical cold knife cone specimens is accurate in the diagnosis of microinvasive squamous cell carcinoma.
|
Gynecol Oncol
|
2003
|
1.43
|
|
12
|
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
|
J Clin Invest
|
2006
|
1.37
|
|
13
|
Inherited determinants of ovarian cancer survival.
|
Clin Cancer Res
|
2010
|
1.32
|
|
14
|
Surgical stage I endometrial cancer: predictors of distant failure and death.
|
Gynecol Oncol
|
2002
|
1.30
|
|
15
|
Adenomatoid tumor of the adrenal gland: a clinicopathologic study of five cases and review of the literature.
|
Am J Surg Pathol
|
2003
|
1.26
|
|
16
|
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.22
|
|
17
|
Bone metastases in endometrial cancer: report on 19 patients and review of the medical literature.
|
Gynecol Oncol
|
2013
|
1.17
|
|
18
|
The impact of multi-modal therapy on survival for uterine carcinosarcomas.
|
Gynecol Oncol
|
2009
|
1.17
|
|
19
|
Predictors of lymphatic failure in endometrial cancer.
|
Gynecol Oncol
|
2002
|
1.17
|
|
20
|
Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
|
J Reprod Med
|
2007
|
1.17
|
|
21
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.14
|
|
22
|
Endometrial carcinoma: paraaortic dissemination.
|
Gynecol Oncol
|
2004
|
1.11
|
|
23
|
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
|
J Cell Biochem
|
2007
|
1.09
|
|
24
|
A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer.
|
Gynecol Oncol
|
2012
|
1.05
|
|
25
|
Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins.
|
Ann Surg Oncol
|
2011
|
1.03
|
|
26
|
Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.
|
Gynecol Oncol
|
2007
|
1.03
|
|
27
|
Stage IIIC endometrioid corpus cancer includes distinct subgroups.
|
Gynecol Oncol
|
2002
|
1.02
|
|
28
|
Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer.
|
Gynecol Oncol
|
2003
|
1.02
|
|
29
|
Assessment of prognostic factors in stage IIIA endometrial cancer.
|
Gynecol Oncol
|
2002
|
1.02
|
|
30
|
Endometrial cancer: predictors of peritoneal failure.
|
Gynecol Oncol
|
2003
|
1.01
|
|
31
|
High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.
|
Gynecol Oncol
|
2004
|
1.01
|
|
32
|
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.
|
Int J Mol Epidemiol Genet
|
2011
|
1.00
|
|
33
|
Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.00
|
|
34
|
Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses.
|
Gastrointest Endosc
|
2002
|
0.99
|
|
35
|
Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
|
Gynecol Oncol
|
2007
|
0.98
|
|
36
|
Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
|
Gynecol Oncol
|
2013
|
0.97
|
|
37
|
Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer.
|
Gynecol Oncol
|
2005
|
0.97
|
|
38
|
FOXL2 mutations in granulosa cell tumors occurring in males.
|
Arch Pathol Lab Med
|
2012
|
0.95
|
|
39
|
Predictors of vaginal relapse in stage I endometrial cancer.
|
Gynecol Oncol
|
2005
|
0.94
|
|
40
|
Hepatic resection for metachronous metastases from ovarian carcinoma.
|
Gynecol Oncol
|
2003
|
0.94
|
|
41
|
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma.
|
Gynecol Oncol
|
2011
|
0.93
|
|
42
|
Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer.
|
Gynecol Oncol
|
2012
|
0.93
|
|
43
|
High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
|
Am J Surg Pathol
|
2014
|
0.93
|
|
44
|
Outcome of surgical treatment for primary malignant melanoma of the female urethra.
|
J Urol
|
2004
|
0.92
|
|
45
|
Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower genital tract.
|
Genes Chromosomes Cancer
|
2007
|
0.90
|
|
46
|
Nearly identical near-haploid karyotype in a peritoneal mesothelioma and a retroperitoneal malignant peripheral nerve sheath tumor.
|
Cancer Genet Cytogenet
|
2010
|
0.90
|
|
47
|
ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
|
Arch Pathol Lab Med
|
2012
|
0.89
|
|
48
|
Risk factors for developing multiple malignancies in patients with endometrial cancer.
|
Int J Gynecol Cancer
|
2011
|
0.86
|
|
49
|
Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma.
|
Gynecol Oncol
|
2012
|
0.84
|
|
50
|
A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis.
|
PLoS One
|
2013
|
0.82
|
|
51
|
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
|
Gynecol Oncol
|
2005
|
0.81
|
|
52
|
Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.
|
Obstet Gynecol
|
2010
|
0.81
|
|
53
|
Epigenetic regulation of uterine biology by transcription factor KLF11 via posttranslational histone deacetylation of cytochrome p450 metabolic enzymes.
|
Endocrinology
|
2014
|
0.79
|
|
54
|
Collision tumor of the ovary: adult granulosa cell tumor and endometrioid carcinoma.
|
Int J Gynecol Pathol
|
2012
|
0.79
|
|
55
|
Long-term follow-up of women with ovarian cancer after positive second-look laparotomy.
|
Gynecol Oncol
|
2003
|
0.78
|
|
56
|
Role of bcl-2 in endometrioid corpus cancer: an experimental study.
|
Anticancer Res
|
2006
|
0.78
|
|
57
|
Endometrial cancer: can nodal status be predicted with curettage?
|
Gynecol Oncol
|
2005
|
0.78
|
|
58
|
Treatment of pulmonary recurrences in patients with endometrial cancer.
|
Gynecol Oncol
|
2007
|
0.77
|
|
59
|
Molecular and histopathologic predictors of distant failure in endometrial cancer.
|
Cancer Detect Prev
|
2003
|
0.77
|
|
60
|
HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.
|
Anticancer Res
|
2005
|
0.77
|
|
61
|
Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
|
Am J Surg Pathol
|
2011
|
0.76
|
|
62
|
Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall.
|
Int J Gynecol Pathol
|
2015
|
0.76
|
|
63
|
Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
|
Am J Surg Pathol
|
2017
|
0.75
|
|
64
|
Distribution and volume of extrauterine disease in uterine serous carcinoma: is minimally invasive surgery a suitable approach?
|
Int J Gynecol Cancer
|
2015
|
0.75
|
|
65
|
Ovarian Hemangiomas Do Not Harbor EWSR1 Rearrangements: Clinicopathologic Characterization of 10 Cases.
|
Int J Gynecol Pathol
|
2015
|
0.75
|
|
66
|
Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?
|
Int J Gynecol Cancer
|
2010
|
0.75
|
|
67
|
Genital Rhabdomyoma of the Lower Female Genital Tract: A Study of 12 Cases With Molecular Cytogenetic Findings.
|
Int J Gynecol Pathol
|
2017
|
0.75
|